Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FIREFLY NEUROSCIENCE, INC.
Report date November 15, 2021 · Filed November 17, 2021
Section 16 reporting ended · disclosed 2021-11-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2026-11-15 | Direct | 192,000 |
Reported balance
After 2021-11-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-11-15 · Grant · Acquired 20,000 · Balance 192,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2021 Filed Nov 17, 2021 23:56 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | GrantOptions (Right-to-Buy) · Derivative | 20,000 | $3.15 Strike: $3.15 | $63,000.00 |
DisclosureSEC source: 0001806533-21-000007 · primary_doc.xml · derivative · entry 1 SANDS MATTHEW T · CIK 0001806533 · Former Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,000 Underlying: Common Stock · 20,000 shares Expires 2026-11-15 Read SEC document |
| May 05, 2021 Filed May 5, 2021 13:05 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | OtherOptions (Right-to-Buy) · Derivative | 10,000 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001806533-21-000003 · primary_doc.xml · derivative · entry 6 SANDS MATTHEW T · CIK 0001806533 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,000 Underlying: Common Stock · 10,000 shares Expires 2022-06-12 F1 · price: 1. Per Instruction 4.(c)(iii), Since the transaction is the exercise of a derivative security, column 8 is left blank and the exercise price is reported in column 2. Read SEC document |
| May 05, 2021 Filed May 5, 2021 13:05 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | OtherOptions (Right-to-Buy) · Derivative | 10,000 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001806533-21-000003 · primary_doc.xml · derivative · entry 5 SANDS MATTHEW T · CIK 0001806533 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,000 Underlying: Common Stock · 10,000 shares Expires 2022-06-12 F1 · price: 1. Per Instruction 4.(c)(iii), Since the transaction is the exercise of a derivative security, column 8 is left blank and the exercise price is reported in column 2. Read SEC document |
| May 05, 2021 Filed May 5, 2021 13:05 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | OtherOptions (Right-to-Buy) · Derivative | 4,000 | Not disclosed Strike: $0.16 | Not disclosed |
DisclosureSEC source: 0001806533-21-000003 · primary_doc.xml · derivative · entry 4 SANDS MATTHEW T · CIK 0001806533 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,000 Underlying: Common Stock · 4,000 shares Expires 2021-05-26 F1 · price: 1. Per Instruction 4.(c)(iii), Since the transaction is the exercise of a derivative security, column 8 is left blank and the exercise price is reported in column 2. Read SEC document |
| May 05, 2021 Filed May 5, 2021 13:05 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | OtherOptions (Right-to-Buy) · Derivative | 4,000 | Not disclosed Strike: $0.16 | Not disclosed |
DisclosureSEC source: 0001806533-21-000003 · primary_doc.xml · derivative · entry 3 SANDS MATTHEW T · CIK 0001806533 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,000 Underlying: Common Stock · 4,000 shares Expires 2021-05-26 F1 · price: 1. Per Instruction 4.(c)(iii), Since the transaction is the exercise of a derivative security, column 8 is left blank and the exercise price is reported in column 2. Read SEC document |
| May 05, 2021 Filed May 5, 2021 13:05 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | OtherCommon Stock | 20,000 | $0.15 | $3,000.00 |
DisclosureSEC source: 0001806533-21-000003 · primary_doc.xml · nonDerivative · entry 2 SANDS MATTHEW T · CIK 0001806533 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Read SEC document |
| May 05, 2021 Filed May 5, 2021 13:05 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | OtherCommon Stock | 8,000 | $0.16 | $1,280.00 |
DisclosureSEC source: 0001806533-21-000003 · primary_doc.xml · nonDerivative · entry 1 SANDS MATTHEW T · CIK 0001806533 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| September 02, 2020 Filed Sep 2, 2020 20:55 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | GrantOptions (Right-to-Buy) · Derivative | 100,000 | $0.66 Strike: $0.66 | $66,000.00 |
DisclosureSEC source: 0001437749-20-019235 · rdgdoc.xml · derivative · entry 2 SANDS MATTHEW T · CIK 0001806533 · Acting Principal Financial Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2030-09-02 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.